For many patients across a wide range of therapeutic areas, participation in a clinical trial can provide access to important life-saving medications. However, the efficient conduct of studies has long been complicated by complex protocols, inefficient recruiting methods and logistics that can make participation burdensome, if not impossible. Read this article to see how CROs and clinical services companies are striving to facilitate patient access and become more patient-centric by improving recruitment processes and easing the burden of participation to enhance patient engagement before, during, and after the study.
Author: Kurt Mussina, MBA
European Pharmaceutical Contractor | February 2018, pages 12-15. © Samedan Ltd.